Intelligence · Patents

Patents expiring in 2029

Annual patent cliff calendar for 2029 — US pharmaceutical patents by expiration date.

Patents
675

Quick answer

675 indexed pharmaceutical patents have expiration dates in 2029. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7550595

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7550275

    Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide

    United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7550460

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7550587

    Photosensitizer and method for production thereof

    Obschestvo S Ogranichennoi Otvetstvennostiju “Rada-Pharma” · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7550454

    Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

    ACADIA Pharmaceuticals Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7550459

    Tetrahydroquinoline analogues as muscarinic agonists

    ACADIA Pharmaceuticals Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7550141

    Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7550005

    Coated implantable medical device

    Cook Regentec LLC · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7550590

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7550598

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7553962

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7553484

    Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule

    The Regents of the University of California · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7553840

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7553490

    Vaccines against Escherichia coli O157 infection

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7554021

    Composition and method for self-assembly and mineralization of peptide amphiphiles

    Northwestern University · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7553971

    Aryl aniline β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7553931

    Complement depletion using recombinant human C3-derivatives

    PLS-Design GmbH · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7553867

    Furan or thiophene derivative and medicinal use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7553855

    Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7553935

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7553934

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7553653

    Variants and chemically-modified variants of phenylalanine ammonia-lyase

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7553852

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7553936

    Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7557194

    Antibody materials for an IBD-associated polypeptide

    The Regents of the University of California · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7557096

    Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7556942

    Tumor suppressor designated Hippo

    The Board of Regents of the University of Texas System · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7556927

    Methods for diagnosing, imaging and treating atherosclerotic disease

    The Regents of the University of California · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7557251

    Production of gossypol co-crystals

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7557212

    Tricyclic derivatives as LTD4 antagonists

    Laboratories Almirall, S.A. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7557247

    Crystalline form of β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7557196

    hGC-1, a gene encoding a member of the olfactomedin-related protein family

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7557207

    Spiro 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7557106

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7557126

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7557084

    IL-18 specific polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7556926

    Methods for screening insulin-sensitizing agents

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7556804

    Anti-HGF-R antibodies and their use

    UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7557138

    5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel

    The Regents of the University of California · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7557210

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7557081

    Alpha-1-acid glycoprotein for the treatment of diabetes

    Essential Skincare, LLC · Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7560471

    Indolylpiperidine derivatives as potent antihistaminic and antiallergic agents

    Laboratories Almirall, S.A. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7560469

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7560466

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7560440

    Regulation of angiogenesis with zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7560437

    Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7560265

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7560229

    Methods of use of the enzymes of mycothiol synthesis

    The Regents of the University of California · Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2029?

675 published patents in our USPTO index have expiration dates falling in calendar year 2029.